Gypenosides ameliorate high-fat diet-induced nonalcoholic fatty liver disease in mice by regulating lipid metabolism
Gypenosides (GP), extracted from the traditional Chinese herb Gynostemma pentaphyllum (Thunb.) Makino, have been used to treat metabolic disorders, including lipid metabolism disorders and diabetes. Although recent studies have confirmed their beneficial effects in nonalcoholic fatty liver disease (...
Main Authors: | Tingting Zhou, Ligang Cao, Yimei Du, Lin Qin, Yanliu Lu, Qianru Zhang, Yuqi He, Daopeng Tan |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2023-04-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/15225.pdf |
Similar Items
-
Gypenoside XIII regulates lipid metabolism in HepG2 hepatocytes and ameliorates nonalcoholic steatohepatitis in mice
by: Shu‐Chen Cheng, et al.
Published: (2024-03-01) -
Gypenoside XLIX Ameliorate High-Fat Diet-Induced Atherosclerosis via Regulating Intestinal Microbiota, Alleviating Inflammatory Response and Restraining Oxidative Stress in ApoE<sup>−/−</sup> Mice
by: Ming Gao, et al.
Published: (2022-08-01) -
Gypenosides and capsaicinoids in combination ameliorates high-fat-diet- induced rat hyperlipidemia via the PPARγ-LXRα-ABCA1/ABCG1 pathway
by: Fangbo Zhang, et al.
Published: (2023-09-01) -
Gypenosides Synergistically Reduce the Extracellular Matrix of Hepatic Stellate Cells and Ameliorate Hepatic Fibrosis in Mice
by: Han Li, et al.
Published: (2023-07-01) -
Gypenoside alleviates injury of rat adrenal pheochromocytoma cell line PC12 induced by lipopolysaccharide
by: JIANG Xiu-fang, GENG Ya-nan, YANG Sheng-hong, WEI Ping, ZHAO Ming, ZHU Ling-ling
Published: (2022-06-01)